CellCentric
Biotechnology
Little Chesterford, United Kingdom
46 employees
- Employees
- 46
- Contacts
- 2
- Emails
- 2
- Phones
- 1
CellCentric Overview
- Headquarters
- Little Chesterford, United Kingdom
- Website
- www.cellcentric.com
- Industry
- Biotechnology
- Employees
- 46
- Funding
- 120.0M
Keywords
About CellCentric
Inobrodib is the first small molecule drug in the clinic targeting twin proteins p300 and CBP. It is formulated as a capsule taken orally. p300/CBP are twin (paralogue) acetyl transferases, and importantly, gene activating proteins that are known to play an important role in the progression of certain cancers. CellCentric’s pioneering drug is in Phase I/II clinical trials to evaluate its effectiveness to treat specific solid tumours, as well as haematological malignancies (blood cancers). These represent major clinical unmet needs, delivering a new therapy for people with cancer, who otherwise have few alternatives.
CellCentric Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
- Phone contacts
- 1
- 25.0% coverage
CellCentric Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Celia Economides | San Francisco, California, United States |
Email
Phone
|
|
| Jacob, Valeria | Clinical Operations Director |
View
|
|
| Kris Frese | Director of Cancer Biology | Manchester, England, United Kingdom |
Email
|
| Debbie Haynes | Chief Operating Officer at Cellcentric |
View
|
Employees by Management Level
Director
2 profiles
Executive
1 profile
Compare Similar Companies to CellCentric
Autolus Therapeutics
Biotechnology
cellcentric GmbH & Co. KG
Fuel Cell Manufacturing
Bicycle Therapeutics
Biotechnology Research
Quell Therapeutics
Biotechnology Research
Amphista Therapeutics Limited
Biotechnology Research
Apollo Therapeutics
Biotechnology Research
Evox Therapeutics Ltd
Research Services
Ellipses Pharma
Biotechnology
AstronauTx
Biotechnology Research
Crescendo Biologics Limited
Biotechnology Research